North America Infectious Respiratory Disease Diagnostics Market Size & Outlook

Name: North America Infectious Respiratory Disease Diagnostics Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The infectious respiratory disease diagnostics market in North America is expected to reach a projected revenue of US$ 6,870.9 million by 2033. A compound annual growth rate of 2.6% is expected of North America infectious respiratory disease diagnostics market from 2025 to 2033.

Clinical Diagnostics
- In Vitro Diagnostics
  - Infectious Respiratory Disease Diagnostics Market Outlook

North America infectious respiratory disease diagnostics product outlook (Revenue, USD million, 2021-2033)
- Instruments
- Reagents
- Services
North America infectious respiratory disease diagnostics technology outlook (Revenue, USD million, 2021-2033)
- Molecular Diagnostics
- Immunoassays
- Microbiology
- Rapid/Point-of-Care Diagnostics
- Other Technologies
North America infectious respiratory disease diagnostics application outlook (Revenue, USD million, 2021-2033)
- COVID-19
- Influenza
- Tuberculosis
- Respiratory Syncytial Virus (RSV)
- Non-tuberculosis Mycobacterium Testing
- Bacterial Pneumonia Testing
- Other Respiratory Diseases
North America infectious respiratory disease diagnostics end use outlook (Revenue, USD million, 2021-2033)
- Hospitals
- Clinics
- Diagnostics Laboratories
- Research Institutes

North America Infectious Respiratory Disease Diagnostics Market Size & Outlook

Data Tree

Sign up - it's easy, and free!